Tandem Diabetes Care, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Tandem Diabetes Care, Inc. (TNDM) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-02-26
- Tandem Diabetes Care, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.00.
- Tandem Diabetes Care, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $65.28, a 24.69% decline from fiscal 2021.
- Tandem Diabetes Care, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $86.68, a 3.75% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 | |
| 2022-12-31 | $65.28 10-K · filed 2025-02-26 | |
| 2021-12-31 | $86.68 10-K · filed 2024-02-21 | |
| 2020-12-31 | $83.55 10-K · filed 2023-02-22 | |
| 2019-12-31 | $54.62 10-K · filed 2021-02-24 | |
| 2018-12-31 | $20.34 10-K · filed 2020-02-24 | |
| 2017-12-31 | $4.69 10-K · filed 2019-02-26 | |
| 2016-12-31 | $45.75 10-K · filed 2018-03-01 | $4.57 10-K · filed 2017-03-08 |
| 2015-12-31 | $12.01 10-K · filed 2017-03-08 | |
| 2014-12-31 | $21.26 10-K · filed 2016-02-24 | |
| 2013-12-31 | $7.92 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |